Form 144 Werewolf Therapeutics For: 22 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Werewolf Therapeutics Inc (HOWL)
Assess today's live Werewolf Therapeutics Inc (HOWL) share price, performance and insights using our live NASDAQ: HOWL stock exchange data.
Analyse the historical data and Werewolf Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Werewolf Therapeutics share price buy/sell indicators using real-time data (or discuss the Werewolf Therapeutics (HOWL) stock price today with other investors in the Werewolf Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ HOWL share price (ISIN: US95075A1079) to enhance your trading decisions with our free investment tools and resources.
What Is the Werewolf Therapeutics Inc Share Price Today?
The Werewolf Therapeutics share price today is 0.63.
What Is the Stock Symbol for Werewolf Therapeutics Inc
The stock symbol (or 'ticker') for Werewolf Therapeutics Inc is "HOWL."
What Stock Exchange Does Werewolf Therapeutics Inc Trade On?
Werewolf Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Werewolf Therapeutics Inc a Good Stock to Buy?
Determining whether Werewolf Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Werewolf Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Werewolf Therapeutics share price buy/sell indicators using real-time data (or discuss the Werewolf Therapeutics (HOWL) stock price today with other investors in the Werewolf Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ HOWL share price (ISIN: US95075A1079) to enhance your trading decisions with our free investment tools and resources.
What Is the Werewolf Therapeutics Inc Share Price Today?
The Werewolf Therapeutics share price today is 0.63.
What Is the Stock Symbol for Werewolf Therapeutics Inc
The stock symbol (or 'ticker') for Werewolf Therapeutics Inc is "HOWL."
What Stock Exchange Does Werewolf Therapeutics Inc Trade On?
Werewolf Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Werewolf Therapeutics Inc a Good Stock to Buy?
Determining whether Werewolf Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.61
0.69
52 wk Range
0.56
2.38
HOWL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.610.69
52 wk Range
0.562.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HOWL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
5.20
Upside
+725.40%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Werewolf Therapeutics Inc For: 18 December
- Investing.com
- Form 144 Werewolf Therapeutics For: 22 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Werewolf Therapeutics Company Profile
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Werewolf Therapeutics Inc SWOT Analysis
Innovative Platform | Explore Werewolf Therapeutics' PREDATOR platform, developing conditionally activated proteins for improved efficacy and safety in oncology treatments |
Financial Outlook | Delve into Werewolf's robust cash position, funding operations until Q4 2026, and its impact on advancing clinical programs and strategic initiatives |
Pipeline Progress | Learn about Werewolf's promising candidates, including WTX-124 and WTX-330, with upcoming data releases potentially driving valuation and investor interest |
Analyst Perspectives | Discover varied analyst views on Werewolf, with price targets ranging from $4 to $12, reflecting the company's potential in the competitive biotech landscape |
Compare HOWL to Peers and Sector
Metrics to compare | HOWL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHOWLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −2.1x | −0.6x | |
PEG Ratio | 0.08 | 0.01 | 0.00 | |
Price/Book | 1.0x | 1.7x | 2.6x | |
Price / LTM Sales | - | 228.9x | 3.2x | |
Upside (Analyst Target) | - | 187.5% | 41.8% | |
Fair Value Upside | Unlock | −5.8% | 5.1% | Unlock |
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.20
(+725.40% Upside)
Earnings
Latest Release
Nov 04, 2025
EPS / Forecast
-0.36 / -0.3833
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Werewolf Therapeutics (HOWL) Share Price Today?
The live Werewolf Therapeutics share price today is 0.63
What Stock Exchange Does Werewolf Therapeutics (HOWL) Trade On?
Werewolf Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Werewolf Therapeutics?
The stock symbol (also called a 'ticker') for Werewolf Therapeutics is "HOWL."
What Is the Current Werewolf Therapeutics Market Cap?
As of today, Werewolf Therapeutics market capitalisation is 30.52M.
What Is Werewolf Therapeutics's (HOWL) Earnings Per Share (TTM)?
The Werewolf Therapeutics EPS is currently -1.62 (Trailing Twelve Months).
When Is the Next Werewolf Therapeutics Earnings Date?
Werewolf Therapeutics's next earnings report will be released on 19 Mar 2026.
Is HOWL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Werewolf Therapeutics moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Werewolf Therapeutics Stock Split?
Werewolf Therapeutics has split 0 times. (See the HOWL stock split history page for full effective split date and price information.)
How Many Employees Does Werewolf Therapeutics Have?
Werewolf Therapeutics has 39 employees.
What is the current trading status of Werewolf Therapeutics (HOWL)?
As of 24 Dec 2025, Werewolf Therapeutics (HOWL) is trading at a price of 0.63, with a previous close of 0.67. The stock has fluctuated within a day range of 0.61 to 0.69, while its 52-week range spans from 0.56 to 2.38.
What Is Werewolf Therapeutics (HOWL) Price Target According to Analysts?
The average 12-month price target for Werewolf Therapeutics is USD5.2, with a high estimate of USD10 and a low estimate of USD1. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +725.40% Upside potential.
What Is the HOWL Premarket Price?
HOWL's last pre-market stock price is 0.69. The pre-market share volume is 40,340.00, and the stock has decreased by 0.02, or 3.59%.
What Is the HOWL After Hours Price?
HOWL's last after hours stock price is 0.66, the stock has decreased by 0.03, or 4.76%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.